Christopher Sugahara

Christopher Sugahara is President and Chief Investment Officer of Fairfield-Maxwell Ltd. and serves on the company’s Board of Directors. Fairfield describes him as responsible for overseeing investment activity across the Fairfield group of companies, including subsidiary investment activity, debt financing, and treasury management.

Sugahara is a third-generation member of the Sugahara family, which has owned Fairfield-Maxwell since Keiichi “Kay” Sugahara founded the company in 1957. Fairfield’s history page says that in 2018 Chris Sugahara, together with his siblings and cousins, focused on establishing the Sugahara Family Ownership Board and professionalizing the business.

Before joining Fairfield in 2004, Sugahara worked in finance at Credit Suisse: as an Associate in the Hedge Fund Investments Group at Credit Suisse Asset Management and as an Analyst in the Private Client Services division of Credit Suisse First Boston. He holds a Bachelor of Arts degree from Colgate University; his LinkedIn profile lists Colgate University attendance from 1996 to 2000.

In addition to his Fairfield role, Fairfield’s team page says Sugahara serves as Chairman of Great American Lines and Chairman of SpeedPro Imaging. A board-section bio on the same page also lists him as Chief Executive Officer of Fairfield Geotechnologies.

• Fairfield-Maxwell is not primarily a seed-stage angel investor based on current public materials; its stated focus is majority-control middle-market leveraged buyouts and long-term operating-company ownership.
• Fairfield describes its approach as “Long-term,” “Opportunistic,” “Value-oriented,” and “Supportive.”
• The firm seeks companies with competitive advantages in industries likely to experience long-term growth.
• Fairfield looks for management teams with industry expertise and says post-transaction management teams retain flexibility to run operations.
• The firm emphasizes patient capital, stating that it works on long-term strategic plans “without the artificial deadline of an exit date.”
• Fairfield’s stated financial filters are EBITDA of $5-$40 million, gross margin above 25%, low capex needs, positive cash-flow history, and ROIC above 15%.
• In healthcare and neurodiversity, Fairfield has backed Autism Impact Fund as an LP and direct-investment partner; Sugahara cited AIF’s team and scientific advisory board as a reason for Fairfield’s conviction.